A Comprehensive Guide to Patent Licensing and Filing Procedure in Turkey

patent licensing

Introduction Turkey has become a regional economic powerhouse with a flourishing economy and a thriving tech sector which attracts the businesses and individuals eager to capitalize on its market opportunities. As the competition is growing day by day it is important to protect the Intellectual Property Rights for both the domestic as well the international […]

A Brief Analysis Of Compulsory Licensing Pertinent To Copyright Law

Introduction As the title suggests, this particular blog deals with the compulsory licensing of copyright in our country. However, in order to understand compulsory licensing, the concept pertinent to “licenses” needs to be grasped first. Licenses are of two categories: one being voluntary license and the other being compulsory license. Section 30 of the Copyright […]

Commentary On Compulsory Licensing Under The Patents Act, 1970

Patents provide exclusive rights to the patent proprietors over their novel creations. There is an implied expectation that the owners of the patents will work the patented inventions pragmatically on a commercial scale without any undue delay. However, in certain cases, these rights are exploited for anti-competitive practices. In order to prevent such abuse, the […]

All You Need to Know About Patent Licensing

What is a patent? An exclusive right granted for an invention, which is either a product or a process, and offers a new way of doing work or provides a new technical solution to an existing problem, is called a patent.[i] What is called Patent Licensing? Patent Licensing is an act of or a process of […]

“Well, You have not made out prima facie case for Compulsory License”: Notifies Rajiv Agarwal, Controller General of Patents, Designs and Trademarks, to Lee Pharma!

In a major update for the patent circle (and of course Pharma industry), reportedly, Lee Pharma, a Hyderabad based Indian pharma company, which had filed a Compulsory Licensing (CL) Application on June 29, 2015, in India, against one of the patented drug Saxagliptin of AstraZeneca (used for treating Diabetes Mellitus), has failed to make out […]